Friday, 4 November 2011

FDA Approves J&J, Bayer Drug Xarelto To Prevent Strokes

WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration on Friday approved Johnson & Johnson (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xarelto as a treatment to prevent strokes in patients with atrial fibrillation. Xarelto was already approved in the U.S. as a short-term ...


Related News:-

  • Drugs@FDA


  • A searchable catalog of FDA approved drug products both prescription and over the counter. The database includes information such as therapeutic equivalents and links to ...
  • Press Announcements


  • Sign up to receive FDA Press Releases. Note: Some links in press announcements are no longer active, but remain for archival purposes. For more information, contact the FDA's ...
  • FDA approves Gilead-J&J HIV pill Complera


  • FOSTER CITY, Calif. (AP) -- The Food and Drug Administration has approved a once-per-day HIV treatment that combines Gilead Sciences Inc.'s drug Truvada with Johnson & Johnson ...

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...